Surgical management of ascending aortic aneurysm due to non-infectious aortitis

Ari A. Mennander, Dylan V. Miller, Kimberly P. Liang, Kenneth J Warrington, Heidi M. Connolly, Hartzell V Schaff, Thoralf M. Sundt

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objectives. We reviewed the spectrum of disease and early outcomes of patients undergoing ascending aortic surgery for Giant cell aortitis (GCA). Design. Of 1 259 patients undergoing repair of ascending aortic aneurysms between January 1993 and July 2006, 100 had histologic evidence of GCA or lymphoplasmacytic aortitis. Results. Operative Mortality was 4% (4/100). One patient underwent aortoplasty and aortic valve replacement (AVR). Among 99 patients undergoing graft replacement of the ascending aorta, distal disease required hemiarch replacement in 33 and total arch replacement in 14. Proximal aneurismal disease of the root was managed by mechanical or biological root replacement (n=18), Yacoub remodeling (n=2) or David reimplantation (n=9). Another 12 patients had separate AVR and ascending graft, while 26 had AR corrected by restoration of proper sinotubular junction diameter. In total, of 63 patients with AR, 38 had a valve-preserving procedure (61%). Conclusions. Ascending aortic aneurismal disease due to GCA is frequently associated with proximal and/or distal disease. Valve sparing procedures are technically feasible for many, although late durability is uncertain.

Original languageEnglish (US)
Pages (from-to)417-424
Number of pages8
JournalScandinavian Cardiovascular Journal
Volume42
Issue number6
DOIs
StatePublished - 2008

Fingerprint

Aortitis
Aortic Aneurysm
Giant Cell Arteritis
Aortic Valve
Transplants
Aortic Diseases
Replantation
Aorta
Mortality

Keywords

  • Ascending aortic aneurysm
  • Non-infectious aortitis
  • Valve sparing surgery

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Surgical management of ascending aortic aneurysm due to non-infectious aortitis. / Mennander, Ari A.; Miller, Dylan V.; Liang, Kimberly P.; Warrington, Kenneth J; Connolly, Heidi M.; Schaff, Hartzell V; Sundt, Thoralf M.

In: Scandinavian Cardiovascular Journal, Vol. 42, No. 6, 2008, p. 417-424.

Research output: Contribution to journalArticle

Mennander, Ari A. ; Miller, Dylan V. ; Liang, Kimberly P. ; Warrington, Kenneth J ; Connolly, Heidi M. ; Schaff, Hartzell V ; Sundt, Thoralf M. / Surgical management of ascending aortic aneurysm due to non-infectious aortitis. In: Scandinavian Cardiovascular Journal. 2008 ; Vol. 42, No. 6. pp. 417-424.
@article{34242ac6f614426e937f7941f24f6849,
title = "Surgical management of ascending aortic aneurysm due to non-infectious aortitis",
abstract = "Objectives. We reviewed the spectrum of disease and early outcomes of patients undergoing ascending aortic surgery for Giant cell aortitis (GCA). Design. Of 1 259 patients undergoing repair of ascending aortic aneurysms between January 1993 and July 2006, 100 had histologic evidence of GCA or lymphoplasmacytic aortitis. Results. Operative Mortality was 4{\%} (4/100). One patient underwent aortoplasty and aortic valve replacement (AVR). Among 99 patients undergoing graft replacement of the ascending aorta, distal disease required hemiarch replacement in 33 and total arch replacement in 14. Proximal aneurismal disease of the root was managed by mechanical or biological root replacement (n=18), Yacoub remodeling (n=2) or David reimplantation (n=9). Another 12 patients had separate AVR and ascending graft, while 26 had AR corrected by restoration of proper sinotubular junction diameter. In total, of 63 patients with AR, 38 had a valve-preserving procedure (61{\%}). Conclusions. Ascending aortic aneurismal disease due to GCA is frequently associated with proximal and/or distal disease. Valve sparing procedures are technically feasible for many, although late durability is uncertain.",
keywords = "Ascending aortic aneurysm, Non-infectious aortitis, Valve sparing surgery",
author = "Mennander, {Ari A.} and Miller, {Dylan V.} and Liang, {Kimberly P.} and Warrington, {Kenneth J} and Connolly, {Heidi M.} and Schaff, {Hartzell V} and Sundt, {Thoralf M.}",
year = "2008",
doi = "10.1080/14017430802023086",
language = "English (US)",
volume = "42",
pages = "417--424",
journal = "Scandinavian Cardiovascular Journal",
issn = "1401-7431",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Surgical management of ascending aortic aneurysm due to non-infectious aortitis

AU - Mennander, Ari A.

AU - Miller, Dylan V.

AU - Liang, Kimberly P.

AU - Warrington, Kenneth J

AU - Connolly, Heidi M.

AU - Schaff, Hartzell V

AU - Sundt, Thoralf M.

PY - 2008

Y1 - 2008

N2 - Objectives. We reviewed the spectrum of disease and early outcomes of patients undergoing ascending aortic surgery for Giant cell aortitis (GCA). Design. Of 1 259 patients undergoing repair of ascending aortic aneurysms between January 1993 and July 2006, 100 had histologic evidence of GCA or lymphoplasmacytic aortitis. Results. Operative Mortality was 4% (4/100). One patient underwent aortoplasty and aortic valve replacement (AVR). Among 99 patients undergoing graft replacement of the ascending aorta, distal disease required hemiarch replacement in 33 and total arch replacement in 14. Proximal aneurismal disease of the root was managed by mechanical or biological root replacement (n=18), Yacoub remodeling (n=2) or David reimplantation (n=9). Another 12 patients had separate AVR and ascending graft, while 26 had AR corrected by restoration of proper sinotubular junction diameter. In total, of 63 patients with AR, 38 had a valve-preserving procedure (61%). Conclusions. Ascending aortic aneurismal disease due to GCA is frequently associated with proximal and/or distal disease. Valve sparing procedures are technically feasible for many, although late durability is uncertain.

AB - Objectives. We reviewed the spectrum of disease and early outcomes of patients undergoing ascending aortic surgery for Giant cell aortitis (GCA). Design. Of 1 259 patients undergoing repair of ascending aortic aneurysms between January 1993 and July 2006, 100 had histologic evidence of GCA or lymphoplasmacytic aortitis. Results. Operative Mortality was 4% (4/100). One patient underwent aortoplasty and aortic valve replacement (AVR). Among 99 patients undergoing graft replacement of the ascending aorta, distal disease required hemiarch replacement in 33 and total arch replacement in 14. Proximal aneurismal disease of the root was managed by mechanical or biological root replacement (n=18), Yacoub remodeling (n=2) or David reimplantation (n=9). Another 12 patients had separate AVR and ascending graft, while 26 had AR corrected by restoration of proper sinotubular junction diameter. In total, of 63 patients with AR, 38 had a valve-preserving procedure (61%). Conclusions. Ascending aortic aneurismal disease due to GCA is frequently associated with proximal and/or distal disease. Valve sparing procedures are technically feasible for many, although late durability is uncertain.

KW - Ascending aortic aneurysm

KW - Non-infectious aortitis

KW - Valve sparing surgery

UR - http://www.scopus.com/inward/record.url?scp=57349174013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57349174013&partnerID=8YFLogxK

U2 - 10.1080/14017430802023086

DO - 10.1080/14017430802023086

M3 - Article

C2 - 18609056

AN - SCOPUS:57349174013

VL - 42

SP - 417

EP - 424

JO - Scandinavian Cardiovascular Journal

JF - Scandinavian Cardiovascular Journal

SN - 1401-7431

IS - 6

ER -